MeSH tree: D12.644.541.500.697
Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid plaques and delays cognitive decline. Researchers from VIB and KU Leuven have now demonstrated the ...
Nov 25, 2025
0
523
In the absence of much federal action, states have enacted dozens of laws this year to lower prescription drug costs for their residents—and many more are considering following suit.
Nov 4, 2025
0
14
The first international trial of an unproven stroke treatment available in the U.S. has concluded that, while harmless, "perispinal" etanercept—injected into the spinal area—is no more effective than an inactive dummy drug, ...
Sep 19, 2025
0
39
1 in 100 people in Britain today live with rheumatoid arthritis (RA). Unlike osteoarthritis (OA), RA is caused not by wear and tear but by the body's immune system attacking its own joints. RA can strike quickly at any age—but ...
Jul 3, 2025
0
46
Spurred by fed-up consumers, states are trying to curb spiraling prescription drug costs by assembling special public boards to investigate and regulate pricing.
Jul 22, 2024
0
30
Arthritis is usually associated with older people, but kids can suffer too. Juvenile idiopathic arthritis (JIA) is the most common type of arthritis in children. It affects about 1 in 1,000 kids under 16 in the UK (roughly ...
Feb 28, 2024
0
48
A Colorado board voted unanimously Feb. 16 to consider setting a maximum price for a drug to treat autoimmune diseases, launching the state into uncharted territory and setting up a possible showdown with the drug's manufacturer.
Feb 19, 2024
0
23
Severe brain injury that develops slowly after preterm births, causing cerebral palsy, may be treatable, new research from the University of Auckland finds.
Sep 29, 2022
0
139
